Prot #C25003: A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date10/2/1310/31/20

Funding

  • ICON Clinical Research, LLC (Prot #C25003)
  • Millennium Pharmaceuticals, Inc (Prot #C25003)